Opko Health has completed its acquisition of Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos. Domiciled in Sao Paulo, Brazil, Silcon expands Opko's presence in Latin America and complements business activities of units in Chile and Mexico, as well as permits commercialisation of the Opko 4KScore prostate cancer test in Brazil as a reference laboratory test, while Opko obtains local approval to market its point-of-care microfluidics disposable test cassettes.
This is the latest in a number of recent acquisitions for Opko, the most prominent of which in the Latin American region was the acquisition of ALS Distrbiuidor, a Chilean Pharmaceutical company. Opko looks set on expanding its presence in this growing region. Through this aquisition and others, Opko has gained access to the three fastest growing regions in the Americas. This should enable the company to gain approval and market its 4KScore test in these regions more easily.